May 15, 2024 – Page 7 – Goldea Capital

Snail, Inc. Reports First Quarter 2024 Financial Results

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

CULVER CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) — Snail, Inc. (NASDAQ: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, today announced financial results for its first quarter ended March 31, 2024. Tony Tian, Co-Chief Executive Officer commented, “I’m absolutely thrilled and humbled to take the helm as Co-CEO of Snail. This Company has an exceptionally talented team, ground-breaking technologies, and iconic franchises, like ARK, that have fostered passionate gamer communities worldwide. As someone who has been an avid ARK player, I have a deep, personal appreciation for the creativity and innovation of our Snail team. I am excited for Snail’s bright future and the opportunity to work with this passionate, talented and dedicated team.” First Quarter...

STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

HORSHAM, Penn., May 15, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended March 31, 2024 and provides a corporate update. First Quarter 2024 Highlights Revenue in the first quarter of 2024 was $6.8 million (-11% YOY) vs. $7.6 million in the first quarter of 2023 Global net recurring revenue in the first quarter of 2024 was $4.7 million (-10% YOY) vs. $5.2 million in the first quarter of 2023, and was negatively impacted by deferred billings Gross domestic recurring billings were $4.6 million (-3% YOY) vs. $4.7 million in the first quarter of 2023; the 3% YOY decline in 1Q24 halted...

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

Dosing of all patients in clinical trial of BT-600 has been successfully completed, with results anticipated in late Q2 2024 Clinical data on device function of the NaviCap™ platform to be presented at DDW on May 19 Partnering process for the BioJet oral delivery platform is progressing well Management will host conference call and webcast today at 4:30 PM Eastern / 1:30 PM Pacific SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today provided a corporate update and reported financial results for the first quarter ended March 31, 2024. “We were gratified to see the excellent interim results from our clinical trial for BT-600, where we observed a pharmacokinetic profile consistent with drug delivery and absorption in the colon,”...

ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

Commercial Launch of Next-Generation Lap-Band® 2.0 FLEX Continues Significant Reduction in Overall Operating Expenses of 51% in the First Quarter of 2024 Compared to the First Quarter of 2023 Implementation of 2024 Cost Reduction Plan Continues, Expected to Reduce Operating Expenses by 55.4% Compared to 2023 Conference Call to be Held at 4:30 pm ET Today IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported financial results for the first quarter ended March 31, 2024 and provided a corporate strategic update. First Quarter 2024 and Subsequent Highlights March 2024: Significantly strengthened the company’s intellectual property portfolio related to an intragastric balloon system. Specifically, received...

Nokia Corporation: Repurchase of own shares on 15.05.2024

Written by Customer Service on May 15, 2024. Posted in Public Companies.

Nokia CorporationStock Exchange Release15 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 15.05.2024 Espoo, Finland – On 15 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* XHEL 409,679 3.58 CEUX – – BATE – – AQEU – – TQEX – – Total 409,679 3.58 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Terra Balcanica Announces Share Consolidation Effective Date

Written by Customer Service on May 15, 2024. Posted in Public Companies.

Vancouver, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) announces that, further to the Company’s press release on May 8th, 2024, the consolidation of the outstanding common shares of the Company (each, a “Common Share”) on the basis of one post-Consolidation Common Share for every three pre-Consolidation Common Shares is anticipated to be made effective for trading purposes on Friday, May 17th, 2024 (the “Effective Date”). It is anticipated that the Common Shares will begin trading on the CSE on a post-Consolidation basis at market open on the Effective Date. The new CUSIP of the Common Shares will be 88089G202 and the new ISIN will be CA88089G2027. Shareholders with physical certificates will receive a letter of transmittal from Computershare...

Caisse Française de Financement Local EMTN 2024-6

Written by Customer Service on May 15, 2024. Posted in Public Companies.

Paris, 15 May 2024 Caisse Française de Financement Local has decided to issue on 17 May 2024 – Euro 500,000,000 fixed rate Obligations Foncières due 17 May 2039. A Stabilisation Manager has been named in the applicable Final Terms. The Base Prospectus dated 12 June 2023 and the supplements to the Base Prospectus dated 22 September 2023, 23 February 2024 and 10 April 2024 relating to the Euro Medium Term Notes Programme approved by the Autorité des Marchés Financiers are available on the website of the issuer (www.caissefrancaisedefinancementlocal.fr), at the registered office of the issuer: 112-114, avenue Emile Zola, 75015 Paris, France, and at the office of the paying agent indicated in the Base Prospectus. The Final Terms relating to the issue will be available on the website of the AMF (www.amf-france.org) and of the Luxembourg Stock...

AB Science reports its revenues for the year 2023 and provides an update on its activities

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures with the European Medicines Agency (EMA) and Health Canada for masitinib in the treatment of amyotrophic lateral sclerosis (ALS) First complete bone marrow response in an acute myeloid leukemia patient in its AB8939 Phase I/II clinical trial New clinical development program for masitinib in sickle cell disease, among the winning projects to be funded under the sixth call for “Hospital-University Research in Health” (Recherche Hospitalo-Universitaire en santé) projects, part of the Future Investments Program Strengthening of intellectual property protection for masitinib in ALS, mastocytosis and prostate...

Nilfisk reports Q1 2024 results: Solid organic growth and robust financial performance in line with plan

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

Nilfisk, a leading global provider of professional cleaning products and services, reported its Q1 2024 results today with solid organic growth and gross margin increase. Revenue was 259.0 mEUR, up 2.6 mEUR compared with Q1 2023. Organic growth for Q1 2024 was 3.7%. The EBITDA margin before special items (bsi) was 13.2%, leading to an EBITDA before special items of 34.2 mEUR. René Svendsen-Tune, CEO of Nilfisk comments on the Q1 results: “Nilfisk delivered a solid set of results in line with plan for Q1 2024. Stabilization in EMEA and a positive change in US momentum delivered volume growth for our Professional Business. We also saw our Service Business continue to grow, alongside a strong rebound from the Consumer Business. Also, we are delighted to announce that we have retained our Gold EcoVadis status”. Nilfisk delivered a significant...

60 Degrees Pharmaceuticals Announces First Quarter 2024 Results

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

Q1 2024 net product revenues increased 515% year-over-year to $105.7 thousand. Gross profit increased from ($55.9 thousand) to $51.0 thousand. WASHINGTON, May 15, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the first fiscal quarter of the 2024 year, ended March 31, 2024. Financial Highlights for the Quarter Ended March 31, 2024: Net product revenues increased approximately 515% from $17.17 thousand for the first quarter of 2023 to approximately $105.7 thousand for first quarter of 2024; the Company credits growth from domestic commercial sales of ARAKODA®. The Company achieved a gross profit of approximately $51.0 thousand in the first quarter of...

Day: May 15, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice